JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.57B |
| 2 |
Occidental Petroleum
OXY
|
+$966M |
| 3 |
Meta Platforms (Facebook)
META
|
+$738M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$661M |
| 5 |
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
|
+$625M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Europe ETF
VGK
|
+$1.54B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$903M |
| 3 |
KMP
KINDER MORGAN ENER PNTRS L.P.
KMP
|
+$865M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$775M |
| 5 |
Freeport-McMoran
FCX
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.23% |
| 2 | Financials | 13.31% |
| 3 | Healthcare | 10.98% |
| 4 | Technology | 10.39% |
| 5 | Industrials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
QLTY
2401
DELISTED
QUALITY DISTR INC FLA
QLTY
| $4.08M | ﹤0.01% |
383,825
-303,528
| -44% | -$3.45M |
2013 Q2
6 quarters
|
|
2402
First Trust Consumer Staples AlphaDEX Fund
FXG
$206M
| $4.07M | ﹤0.01% |
95,570
-72,860
| -43% | -$2.99M |
2013 Q2
6 quarters
|
|
2403
Protolabs
PRLB
$2.36B
| $4.07M | ﹤0.01% |
60,533
-2,013
| -3% | -$132K |
2013 Q2
6 quarters
|
|
2404
Invesco Senior Income Trust
VVR
$442M
| $4.06M | ﹤0.01% |
891,295
+13,365
| +2% | +$61.7K |
2013 Q2
6 quarters
|
|
|
TVTY
2405
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $4.05M | ﹤0.01% |
203,595
+36,999
| +22% | +$604K |
2013 Q2
6 quarters
|
|
2406
KBR
KBR
$4.35B
| $4.04M | ﹤0.01% |
238,649
+10,862
| +5% | +$195K |
2013 Q2
6 quarters
|
|
|
PCYC
2407
DELISTED
PHARMACYCLICS INC
PCYC
| $4.03M | ﹤0.01% |
32,949
+11,082
| +51% | +$1.42M |
2013 Q2
6 quarters
|
|
2408
Atara Biotherapeutics
ATRA
$94.4M
| $4.02M | ﹤0.01% |
+6,010
| New | +$3.67M |
2014 Q4
0 quarters
|
|
2409
Vanguard Morningstar Value ETF
VTV
$186B
| $4M | ﹤0.01% |
47,311
+43,656
| +1,194% | +$3.61M |
2013 Q2
6 quarters
|
|
|
NJ
2410
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $3.99M | ﹤0.01% |
246,040
-58,234
| -19% | -$947K |
2013 Q2
6 quarters
|
|
2411
Dine Brands
DIN
$378M
| $3.99M | ﹤0.01% |
38,470
+31,087
| +421% | +$2.87M |
2013 Q2
6 quarters
|
|
2412
Great Southern Bancorp
GSBC
$866M
| $3.99M | ﹤0.01% |
100,460
-1,180
| -1% | -$42.9K |
2013 Q2
6 quarters
|
|
2413
Ziff Davis
ZD
$1.92B
| $3.97M | ﹤0.01% |
73,645
+37,521
| +104% | +$1.81M |
2013 Q2
6 quarters
|
|
2414
Vanguard Health Care ETF
VHT
$19B
| $3.97M | ﹤0.01% |
31,595
+13,547
| +75% | +$1.66M |
2013 Q2
6 quarters
|
|
2415
CALL
Rio Tinto
RIO
$156B
| $3.96M | ﹤0.01% |
+86,000
| New | +$4.05M |
2014 Q4
0 quarters
|
|
|
HLSS
2416
DELISTED
HOME LN SERVICING SOLUTIONS LTD(CAYMAN ISLANDS)
HLSS
| $3.95M | ﹤0.01% |
202,422
+24,702
| +14% | +$490K |
2013 Q2
6 quarters
|
|
2417
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$18.2B
| $3.94M | ﹤0.01% |
38,956
+5,076
| +15% | +$514K |
2013 Q2
6 quarters
|
|
2418
Teck Resources
TECK
$33.3B
| $3.93M | ﹤0.01% |
288,570
-1,701,233
| -85% | -$26M |
2013 Q2
6 quarters
|
|
2419
CALL
US Bancorp Series B Preferred Stock
USB.PRH
$731M
| $3.93M | ﹤0.01% |
87,400
-110,500
| -56% | -$2.44M |
2014 Q3
1 quarter
|
|
2420
Alkermes
ALKS
$7.17B
| $3.93M | ﹤0.01% |
67,059
+32,289
| +93% | +$1.64M |
2013 Q2
6 quarters
|
|
|
QIHU
2421
PUT
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $3.93M | ﹤0.01% |
68,575
-831,425
| -92% | -$54.9M |
2014 Q3
1 quarter
|
|
2422
PTC Therapeutics
PTCT
$5.31B
| $3.92M | ﹤0.01% |
75,737
+7,873
| +12% | +$347K |
2014 Q3
1 quarter
|
|
|
ANDV
2423
CALL
DELISTED
Andeavor
ANDV
| $3.92M | ﹤0.01% |
52,700
-67,900
| -56% | -$4.79M |
2014 Q3
1 quarter
|
|
2424
iShares Core S&P US Growth ETF
IUSG
$34.8B
| $3.92M | ﹤0.01% |
100,000
-100,000
| -50% | -$3.82M |
2013 Q2
6 quarters
|
|
|
CDR
2425
DELISTED
Cedar Realty Trust, Inc
CDR
| $3.92M | ﹤0.01% |
80,845
-61
| -0.1% | -$2.68K |
2013 Q2
6 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2014 Portfolio in Review
As of Q4 2014, JP Morgan Chase held 4,595 positions worth $437B, up 3.7% from $422B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2014 filing shows 424 new, 1,620 increased, 1,864 reduced and 391 closed positions. Its largest new stake was TRIBUNE MEDIA COMPANY CLASS A: 10,171,721 shares worth $608M. The largest sale was Vanguard FTSE Europe ETF, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2014 buy was TRIBUNE MEDIA COMPANY CLASS A: 10,171,721 shares worth $608M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $2.57B increase.
- JP Morgan Chase's biggest Q4 2014 reduction was Vanguard FTSE Europe ETF, cutting an estimated $1.54B.
- JP Morgan Chase fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $865M.
- JP Morgan Chase's ten largest holdings make up 16% of its $437B portfolio in Q4 2014.
- JP Morgan Chase opened 424 new positions and closed 391 in Q4 2014.
- JP Morgan Chase's portfolio value rose 3.7% quarter-over-quarter to $437B.
Based on JP Morgan Chase's 13F filing for Q4 2014, filed 13 Feb 2015.